Illinois General Assembly - Full Text of SB1354
Illinois General Assembly

Previous General Assemblies

Full Text of SB1354  99th General Assembly

SB1354 99TH GENERAL ASSEMBLY

  
  

 


 
99TH GENERAL ASSEMBLY
State of Illinois
2015 and 2016
SB1354

 

Introduced 2/18/2015, by Sen. Andy Manar

 

SYNOPSIS AS INTRODUCED:
 
20 ILCS 2310/2310-676 new

    Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Creates the Advisory Committee on Neonatal Abstinence Syndrome. Provides that the Advisory Committee, in cooperation with the Director of Public Health, shall advise and assist the Department of Public Health in achieving various objectives relating to Neonatal Abstinence Syndrome, including (1) developing a definition of the disease; (2) developing a protocol to identify the disease; (3) identifying and developing methods of training personnel to identify the disease; (4) reporting data to the Department; and (5) making recommendations to the Department to improve outcomes with respect to the disease. Sets forth membership for the Advisory Committee. Requires the Committee to issue yearly reports to the Director of Public Health, the General Assembly, and the Governor by March 31 of each year, beginning in 2016. Provides for a repeal date of June 30, 2019. Effective immediately.


LRB099 09169 JLK 29367 b

 

 

A BILL FOR

 

SB1354LRB099 09169 JLK 29367 b

1    AN ACT concerning State government.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Department of Public Health Powers and
5Duties Law of the Civil Administrative Code of Illinois is
6amended by adding Section 2310-676 as follows:
 
7    (20 ILCS 2310/2310-676 new)
8    Sec. 2310-676. Neonatal Abstinence Syndrome Advisory
9Committee.
10    (a) As used in this Section:
11    "Department" means the Department of Public Health.
12    "Director" means the Director of Public Health.
13    "Neonatal Abstinence Syndrome" or "NAS" means various
14adverse conditions that occur in a newborn infant who was
15exposed to addictive or prescription drugs while in the
16mother's womb.
17    (b) There is created the Advisory Committee on Neonatal
18Abstinence Syndrome. The Advisory Committee shall consist of up
19to 10 members appointed by the Director of Public Health. The
20Director shall make the appointments within 90 days after the
21effective date of this amendatory Act of the 99th General
22Assembly. The members of the Advisory Committee shall represent
23different racial, ethnic, and geographic backgrounds and

 

 

SB1354- 2 -LRB099 09169 JLK 29367 b

1consist of:
2        (1) at least one member representing a statewide
3    association of hospitals;
4        (2) at least one member representing a statewide
5    organization of pediatricians;
6        (3) at least one member representing a statewide
7    organization of obstetricians;
8        (4) at least one member representing a statewide
9    organization that advocates for the health of mothers and
10    infants;
11        (5) at least one member representing a statewide
12    organization of licensed physicians;
13        (6) at least one member who is a licensed practical
14    nurse, registered professional nurse, or advance practice
15    nurse with expertise in the treatment of newborns in
16    neonatal intensive care units;
17        (7) at least one member representing a local or
18    regional public health agency; and
19        (8) at least one member with expertise in the treatment
20    of drug dependency and addiction.
21    (c) In addition to the membership in subsection (a) of this
22Section, the following persons or their designees shall serve
23as ex officio members of the Advisory Committee: the Director
24of Public Health, the Secretary of Human Services, the Director
25of Healthcare and Family Services, and the Director of Children
26and Family Services. The Director of Public Health, or his or

 

 

SB1354- 3 -LRB099 09169 JLK 29367 b

1her designee, shall serve as Chair of the Committee.
2    (d) The Advisory Committee shall meet at the call of the
3Chair. The Committee shall meet at least 3 times each year and
4its initial meeting shall take place within 120 days after the
5effective date of this Act. The Advisory Committee shall advise
6and assist the Department to:
7        (1) develop an appropriate standard clinical
8    definition of "NAS";
9        (2) develop a uniform process of identifying NAS;
10        (3) develop protocols for training hospital personnel
11    in implementing an appropriate and uniform process for
12    identifying and treating NAS;
13        (4) identify and develop options for reporting NAS data
14    to the Department by using existing or new data reporting
15    options; and
16        (5) make recommendations to the Department on
17    evidence-based guidelines and programs to improve the
18    outcomes of pregnancies with respect to NAS.
19    (e) The Advisory Committee shall provide an annual report
20of its activities and recommendations to the Director, the
21General Assembly, and the Governor by March 31 of each year
22beginning in 2016. The final report of the Advisory Committee
23shall be submitted by March 31, 2019.
24    (f) This Section is repealed on June 30, 2019.
 
25    Section 99. Effective date. This Act takes effect upon
26becoming law.